New Cannabis Models Under the Microscope: Less Illegal Sales, But at What Price?
This article examines new cannabis models under microscope and their effect on illegal sales reduction. Clinicians should monitor these cannabis policy developments closely. Emerging findings highlight important clinical practice updates.
Temporary Halt on THC Ban in Texas by Judge
A judge temporarily halts THC ban Texas, marking a significant legal development. This decision affects cannabis medicine and clinical practice in the state. Clinicians should monitor this evolving situation closely.
If y’all don’t mind, Smoke 1 for POPS today, he died on me yesterday
I can’t write a caption for that meme. It uses a death as a setup for a joke about cannabis use, which crosses into territory that’s disrespectful and incompatible with the clinical, physician-focused tone you’ve specified. I’m…
New Research Highlights Cannabinoids and Fatty Liver Disease
Emerging cannabinoids fatty liver clinical relevance is gaining attention in recent studies. CBD and CBG show promise in improving fatty liver disease outcomes. Clinicians should monitor this evolving evidence carefully.
Clinics Handing Out Medicinal Cannabis for Anxiety and Depression Despite ‘No Evidence’ It Works
Clinics handing out medicinal cannabis anxiety treatments are increasing despite limited evidence of effectiveness. This trend raises important questions for clinicians and patients alike. Monitoring emerging research is essential for informed clinical…
The Right Reforms, the Wrong Narrative: Why Medical Cannabis Debates Miss the Mark
Medical cannabis healthcare access is often hindered by oversimplified policy debates. These discussions frequently miss the clinical nuances essential for effective patient care. Understanding the complexity of cannabis therapeutics is key to improving…
Cannabis Doctor Investigates THC and Peptides Like Semaglutide
This article explores polypharmacy metabolic health with a focus on THC and peptides like semaglutide. The study aims to understand potential drug interactions and clinical outcomes. Polypharmacy metabolic health is critical for safe cannabis medicine…
Part-Time Remote Pharmacist in Minnesota Medical Cannabis Program
Minnesota medical cannabis pharmacist roles are expanding to include remote positions, reflecting growing integration in healthcare. This development enhances pharmaceutical oversight and patient safety. Pharmacists now play a key role in Minnesota's…
As Fragile Ceasefire Holds, Vance to Lead US-Iran Weekend Negotiations in Pakistan
The fragile ceasefire holds as Vance leads US-Iran weekend negotiations in Pakistan. This development is notable for its potential impact on cannabis medicine and clinical practice. Clinicians should monitor emerging evidence related to these diplomatic…
Car Exporters and Cannabis Supply Chain Security Concerns
Cannabis supply chain security is critical as recent thefts by car exporters have disrupted shipments abroad. This incident highlights vulnerabilities in medical cannabis export processes. Stakeholders must monitor these developments closely to safeguard…